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Introduction
Aging is clearly agreed to be critical in the etiology of  metabolic 
decline in most human subjects as they near their 65th birthday. A 
great many human subjects at 65 years of  age demonstrate clear 
signs of  metabolic and physiological decline, atherosclerosis in 
most major arteries, high blood pressure, high serum cholesterol 
levels, diverse cardiovascular diseases, and often type 2 diabetes 
mellitus, which contribute in major ways to congestive heart 
failure by their 75th-85th years. It must be pointed out, here, that 
all of  these aberrations have been shown (or to be associated 
with) both experimentally and clinically, with the presence of  
magnesium deficiency (MgD) when they are carefully looked for 
[1-10].
Magnesium deficiency and cardiovascular diseases
Disturbances in diet are known to promote lipid deposition and 
accelerate the growth and transformation of  smooth muscle cells 
in the vascular walls and to promote cardiac dysfunction [3, 9-11]. 
Several epidemiologic studies in North America and Europe 
have shown that people consuming Western-type diets are low 
in magnesium (Mg) content (i.e., 30-65% of  the RDA for Mg 
[8-10, 12, 13]; most such diets in the U.S.A. show that 60-80% 
of  Americans are consuming 185-235 mg/day of  Mg [8, 13]. In 
1900, in contrast, Americans were consuming 450-550 mg/day 
of  Mg [5, 8]. Low Mg content of  drinking water, found in areas 
of  soft-water and Mg-poor soil, is associated with high incidences 
of  atherosclerosis, ischemic heart disease (IHD), coronary 
vasospasm, hypertension, and sudden-cardiac death (SCD) [2, 5, 
8, 14-18]. Both animal and human studies have shown an inverse 
relationship between dietary intake of  Mg and atherosclerosis [5, 
6, 8, 9, 19-21]. The myocardial level of  Mg has consistently been 
observed to be lower in subjects dying from IHD and SCD in 
soft-water areas than those in hard-water areas [2, 4-6, 8, 9, 19-21]. 
Mg plays essential roles in more than 500 enzymatic reactions in 
the body and is required for all energy-generating reactions and 
oxidative phosphorylation [22]. More than 45 years ago, two of  
us demonstrated that Mg2+ behaves as a natural calcium channel 
blocker in both cardiac and vascular smooth muscle (VSM) cells 
[2, 23-26]. We also showed in experimental animals that Mg 
behaves as a natural statin in that it can lower blood cholesterol 
and triglyceride levels as well as act as a powerful vasodilator 
in the microcirculation and cardiac muscle relaxant [4, 6-8, 19, 
27-30]. Hypermagnesemic diets have been shown to ameliorate 
hypertension and atherogenesis [1-6, 8-10, 19-22, 32-34]. Using 
sensitive and newly designed specific Mg2+-ion selective electrodes, 
our laboratories demonstrated that patients with hypertension, 
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IHD, cardiac failure, strokes, diabetes types 1 and 2, gestational 
diabetes, renal-induced vascular changes (associated with elevated 
serum cholesterol), preeclampsia, hemorrhage, sickle cell anemia 
in children (and adults), and atherosclerosis exhibit significant 
reductions in serum/plasma/whole blood levels of  ionized, but 
not total blood levels of  Mg [5, 6, 8, 34-56]. Our group has also 
shown that dietary deficiency in rabbits and rats causes vascular 
remodeling concomitant with atherogenesis (i.e., arteriolar wall 
hypertrophy and alterations in the matrices of  the vascular walls) 
and hypertension [4-6, 8, 19, 57-59]. These exciting results have 
been confirmed, essentially, by other investigators [20, 21, 32, 
33]. Some of  these results have recently been observed to result 
in an acceleration of  the aging process [60, 61]. A number of  
the pathophysiological and molecular-biochemical alterations 
typically noted in tissues and cells in the aging process have been 
noted in MgD tissues and cells recently by our group and some 
other investigators [4, 6-8, 19, 61-72].
Magnesium deficiency associated with pathophysiological 
and biochemical alterations characteristic of  aging tissues 
and cells: relationship to telomerases, ceramide, NF-kB and 
proto-oncogenes
It is well-known that the aging process is associated with 
elevations in blood/serum/tissue/cell levels of  many of  the 
same proinflammatory cytokines and chemokines found in 
MgD animals, eg., IL-1, IL-2, IL-6, TNF-alpha, among others 
[for recent reviews, see [61]]. Reduced levels of  telomerases are 
known to be associated with elevated levels of  several cytokines 
(e.g., TNF-alpha) in a number of  aged cell types as well as in 
serum and cardiovascular tissues and VSM cells of  MgD animals 
[for recent review, see [61]]; these phenomena being associated 
with (and correlated to ionized Mg levels; ceramide generation; 
and activation of  NF-kB and proto-oncogene pathways) [61, 67, 
68, 74-76]. It should be pointed out, here, that normal amounts 
of  telomerases in all cell types are required to promote efficient 
cell cycle kinetics and normal cell growth [77, 78]. MgD is well-
known to promote disturbances in cell cycle kinetics [79-81] 
via reactive oxygen and nitrogen species, most likely acting to 
downregulate telomerases [61]. Several studies have demonstrated 
that MgD, both in situ and in vitro, cause formation of  reactive 
oxygen (ROS) and nitrogen species (NOS) [5, 6, 8, 61, 63-69]. 
Interestingly, the increased levels of  cellular ROS and NOS were 
found to be associated with oxidation of  DNA and increased 
levels of  the tumor suppressor gene, increased levels of  p53 and 
ceramide, in cardiovascular tissues and cells of  MgD animals [61, 
67, 68, 74-76].
Magnesium deficiency causes oxidation of  DNA and 
increased levels of  ceramide and p53: possible relation to 
cellular mutations and epigenetics
Recently, our laboratories have shown in animals, subjected to 
21 days of  MgD, that telomerase levels are downregulated and 
coupled to fragmentation and oxidation of  DNA and increased 
levels of  the tumor suppressor gene, p53 [61, 74]. We believe such 
data supports the idea that MgD could lead to multiple mutations 
in the genomes of  multiple cell types found in the initiation of  
atherogenesis and congestive heart failure. Previous studies from 
our group [8, 61-64, 67, 68, 74-76, 82, 83], when viewed in the light 
of  these findings, would lend additional support to the hypothesis 
that mutations and transformations of  VSM cells, endothelial cells, 
and cardiac myocytes caused by MgD, fragmentation of  DNA, 
and oxidation of  DNA(all seen in atherogenesis, hypertension, 
strokes, and congestive heart failure) may play major roles in the 
aging process, thus leading to multiple cardiovascular changes, 
including inflammations of  the vascular walls, high blood presure 
(due to formed elemental changes, release of  ceramides, release 
of  cytokines, excess wall lipid deposition and peroxidation, etc), 
cardiac dysfunctions, and eventual cardiac failure.
Several years ago, we suggested that MgD, by itself, probably acts 
as a genotoxic agent [74, 76]. As is known, one of  ceramide's 
major pathophysiological actions is its ability to induce cell 
differentiation and transformation [83-87]. Abnormal cell 
differentiation, transformation, and growth are pivotal events 
of  atherogenesis, hypertension, and cardiac failure. Hyperplasia 
and cardiovascular hypertrophy are common events in aging, 
atherosclerosis, hypertension, and cardiac failure. However, 
the precise mechanism(s) regulating alterations in tissue mass 
are not completely understood [11, 87]. The tumor suppressor 
protein p53, ceramide, and telomerases are now known to play 
key roles in cell transformation, apoptotic events, and the aging 
process [11, 61, 73, 77, 78]. Both ceramide and p53 can induce 
cell cycle arrest (and senescence), induce programmed cell death, 
and are associated with oxidation and fragmentation of  DNA 
(i.e., genotoxic events) [84-86, 88-91]. MgD can produce all of  
these alterations in multiple cell types, including cardiac and VSM 
cell types [4-6, 8, 59-64, 67, 68, 74-76]. In view of  all of  these 
events noted in MgD animals and cells we would be remiss if  
some discussion regarding the potential role of  epigenetics to 
magnesium deficiency's long-term effects on the aging process 
was not pointed out here. All organisms begin as a single cell, 
which divides through a process of  stem cells creating a mass, via 
a series of  carefully-designed changes in gene expression, which 
is required to form the tissues and cells of  the fetal organism. 
The process of  epigenetics orchestrates which genes have to be 
turned-on in each cell type, and then maintains the particular 
type of  gene expression, or in other words, the particular cell's 
molecular identity via how DNA encodes the gene. Anything 
that produces modifications in the chromatin structure can affect 
a particular gene expression via transcription [92, 93]. Thus, if  
MgD-states are, indeed, genotoxic as we have suggested [74, 
76], then the chromatin structure of  one or more cell types (e.g., 
cardiac, endothelial, or vascular) could be modified and affect one 
or more genes and cell phenotype, as is found in atherogenesis. 
DNA methylation, histone modification, and microRNA 
alterations are known epigenetic pathways. We, thus, believe 
that prolonged MgD-states should be categorized as another 
epigenetic mechanism. But, how could all of  these irreversible 
MgD-induced changes be avoided with ease?
Importance of  Mg supplemented drinking water and 
beverages
Over the past two-plus decades, our laboratories have been 
investigating the utility of  Mg-supplemented or naturally-
occurring spring waters to avoid the pitfalls of  dietary-induced 
MgD-states [4-6, 8, 19, 37, 47, 61-68, 74-76]. Our results, so 
far, bolster the idea that water intake (e.g., from tap waters, well 
waters, bottled waters, beverages using tap/well/spring waters, 
or desalinated waters) in humans should contain at least 25-40 
mg/liter/day of  Mg2+ [61, 68, 74-76]. A number of  experiments 
done in our labs indicate that most, if  not all the cardiovascular 
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manifestations observed in experimental animals found to be 
MgD, can be avoided by supplementing drinking waters with 
appropriate amounts of  Mg2+. The latter inclusion in our diets 
should go a long-way towards the prevention of  cardiovascular 
diseases and ameliorate the aging process of  bodily tissues and 
cells in humans worldwide. Interestingly, on the basis of  our work, 
the World Health Organization has taken our recommendations 
seriously, for the first time [94].
Conclusions
There is a growing awareness that dietary deficiency of  magnesium 
is becoming a serious problem, particularly in the Western World. 
Disturbances in diet are known to promote lipid deposition in 
the arterial walls and accelerate growth and transformation 
of  smooth muscle cells in vascular walls which are linked to 
dietary deficiency of  magnesium. The myocardial level of  Mg 
has consistently been observed to be lowered in humans dying 
from IHD and sudden-cardiac death in soft-water areas than in 
those people living in hard-water areas. Use of  specific Mg2+ ion-
selective electrodes has been useful, clinically, to reveal serious 
underlying Mg- deficient states in patients presenting with various 
cardiovascular diseases (CVD). Mg deficiency (MgD) is associated 
with pathophysiological and biochemical alterations characteristic 
of  aging cells and tissues which are related to upregulation of  
enzymes in the sphingolipid pathway and release of  cytokines, 
ROS, NOS, activation of  NF-kB and proto-oncogenes, resulting in 
cellular production of  free ceramide, p53, and disturbances in cell 
cycle kinetics of  vascular smooth muscle and cardiac muscle cells. 
The consequences of  MgD lead to oxidation and fragmentation 
of  DNA and inflammation in cells of  the cardiovascular system, 
phenomena characteristic of  atherosclerosis, aging, and CVD. We 
suggest that MgD states are genotoxic and, thus, one or more cell 
types (e.g., cardiac, endothelial and/or vascular) could be modified 
and affect one or more genes and cell phenotype, as is found 
in atherogenesis, representing epigenetic cell-induced changes. 
Supplementation of  drinking waters (including beverages) is 
recommended in order to prevent and reduce CVD.
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